C D Rethorst1, D Leonard2, C E Barlow2, B L Willis2, M H Trivedi1, L F DeFina2. 1. Department of Psychiatry,Center for Depression Research and Clinical Care, University of Texas Southwestern Medical Center,Dallas, TX,USA. 2. Cooper Institute,Dallas, TX,USA.
Abstract
BACKGROUND: Depression and metabolic syndrome (MetS) are frequently comorbid disorders that are independently associated with premature mortality. Conversely, cardiorespiratory fitness (CRF) is associated with reduced mortality risk. These factors may interact to impact mortality; however, their effects have not been assessed concurrently. This analysis assessed the mortality risk of comorbid depression/MetS and the effect of CRF on mortality in those with depression/MetS. METHODS: Prospective study of 47 702 adults in the Cooper Center Longitudinal Study. Mortality status was attained from the National Death Index. History of depression was determined by patient response (yes or no) to a standardized medical history questionnaire. MetS was categorized using the American Heart Association/National Heart, Lung, and Blood Institute criteria. CRF was estimated from the final speed/grade of a treadmill graded exercise test. RESULTS: 13.9% reported a history of depression, 21.4% met criteria for MetS, and 3.0% met criteria for both MetS and history of depression. History of depression (HR = 1.24, p = 0.003) and MetS (HR = 1.28, p < 0.001) were independently associated with an increased mortality risk, with the greatest mortality risk among individuals with both a history of depression and MetS (HR = 1.59, p < 0.001). Higher CRF was associated with a significantly lower risk of mortality (p < 0.001) in all individuals, including those with MetS and/or a history of depression. CONCLUSIONS: Those with higher levels CRF had reduced mortality risk in the context of depression/MetS. Interventions that improve CRF could have substantial impact on the health of persons with depression/MetS.
BACKGROUND:Depression and metabolic syndrome (MetS) are frequently comorbid disorders that are independently associated with premature mortality. Conversely, cardiorespiratory fitness (CRF) is associated with reduced mortality risk. These factors may interact to impact mortality; however, their effects have not been assessed concurrently. This analysis assessed the mortality risk of comorbid depression/MetS and the effect of CRF on mortality in those with depression/MetS. METHODS: Prospective study of 47 702 adults in the Cooper Center Longitudinal Study. Mortality status was attained from the National Death Index. History of depression was determined by patient response (yes or no) to a standardized medical history questionnaire. MetS was categorized using the American Heart Association/National Heart, Lung, and Blood Institute criteria. CRF was estimated from the final speed/grade of a treadmill graded exercise test. RESULTS: 13.9% reported a history of depression, 21.4% met criteria for MetS, and 3.0% met criteria for both MetS and history of depression. History of depression (HR = 1.24, p = 0.003) and MetS (HR = 1.28, p < 0.001) were independently associated with an increased mortality risk, with the greatest mortality risk among individuals with both a history of depression and MetS (HR = 1.59, p < 0.001). Higher CRF was associated with a significantly lower risk of mortality (p < 0.001) in all individuals, including those with MetS and/or a history of depression. CONCLUSIONS: Those with higher levels CRF had reduced mortality risk in the context of depression/MetS. Interventions that improve CRF could have substantial impact on the health of persons with depression/MetS.
Authors: Daniel I Galper; Madhukar H Trivedi; Carolyn E Barlow; Andrea L Dunn; James B Kampert Journal: Med Sci Sports Exerc Date: 2006-01 Impact factor: 5.411
Authors: Jonathan Myers; Paul McAuley; Carl J Lavie; Jean-Pierre Despres; Ross Arena; Peter Kokkinos Journal: Prog Cardiovasc Dis Date: 2014-09-28 Impact factor: 8.194
Authors: Jeff K Vallance; Elisabeth A H Winkler; Paul A Gardiner; Genevieve N Healy; Brigid M Lynch; Neville Owen Journal: Prev Med Date: 2011-07-23 Impact factor: 4.018
Authors: Carl J Lavie; Arthur R Menezes; Alban De Schutter; Richard V Milani; James A Blumenthal Journal: Can J Cardiol Date: 2016-07-22 Impact factor: 5.223
Authors: I-Min Lee; Eric J Shiroma; Felipe Lobelo; Pekka Puska; Steven N Blair; Peter T Katzmarzyk Journal: Lancet Date: 2012-07-21 Impact factor: 79.321
Authors: Myrela O Machado; Nicola Veronese; Marcos Sanches; Brendon Stubbs; Ai Koyanagi; Trevor Thompson; Ioanna Tzoulaki; Marco Solmi; Davy Vancampfort; Felipe B Schuch; Michael Maes; Giovanni A Fava; John P A Ioannidis; André F Carvalho Journal: BMC Med Date: 2018-07-20 Impact factor: 8.775